172@29@17@101!~!172@29@0@53!~!|news|tags|alembic-pharma.html|videos|!~!news|moneycontrol|com!~!|controller|tag.php!~!is_mobile=false
alembic pharma
Jump to
32 Results Found
  • Market Headstart: Nifty likely to consolidate further; Axis Bank, L&T earnings today Jan 22, 2020 08:40 AM IST

    Market Headstart: Nifty likely to consolidate further; Axis Bank, L&T earnings today

    Trends on SGX Nifty indicate a positive opening for India, with a 68 points, or 0.56 percent, gain

  • Buy or Sell | Here's why Alembic Pharma is a contra bet Dec 27, 2019 02:17 PM IST

    Buy or Sell | Here's why Alembic Pharma is a contra bet

    Dinesh Rohira, CEO and Founder of 5nance.com has taken a contra view on Alembic Pharmaceuticals.

  • Market Headstart: Nifty50 seen opening flat; Maruti, Ashok Leyland eyed Nov 11, 2019 08:47 AM IST

    Market Headstart: Nifty50 seen opening flat; Maruti, Ashok Leyland eyed

    Trends on SGX Nifty indicate a flat opening for the broader index in India, with a seven-point loss, or 0.06 percent

  • Stocks in the news: TCS, RBL Bank, IRB Infra, TVS Motor, Marico, Rel Infra, MT Educare May 03, 2017 08:13 AM IST

    Stocks in the news: TCS, RBL Bank, IRB Infra, TVS Motor, Marico, Rel Infra, MT Educare

    TCS | Wipro | RBL Bank | IRB Infrastructure | Sun Pharma Advanced Research | Oil India | TVS Motor | Tata Communications | Nestle India | Reliance Infrastructure | MT Educare | United Breweries | JM Financial | Shriram City Union Finance | Inox Leisure and Marico are stocks, which are in the news today.

  • Top buzzing midcap stocks to trade on April 25 Apr 25, 2017 01:12 PM IST

    Top buzzing midcap stocks to trade on April 25

    Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today -- BHEL, M&M, Rallis, Biocon, Indiabulls Housing Finance, Marksans Pharma, MCX, Alembic Pharma, Delta Corp, and Pincon Spirits.

  • Alembic Pharma soars 7% on USFDA inspection clearance Mar 10, 2017 02:48 PM IST

    Alembic Pharma soars 7% on USFDA inspection clearance

    The US drug regulator had inspected its Baroda unit between March 6 and 10 and issued no Form 483s for the same.

  • Expect further upmove in Alembic Pharma, says Jigar Shah Jan 01, 2014 11:17 AM IST

    Expect further upmove in Alembic Pharma, says Jigar Shah

    Jigar Shah of Kim Eng Securities is of the view that one may see further upmove in Alembic Pharmaceuticals.

  • Early gains for generics in Cymbalta patent expiry: Sources Dec 31, 2013 01:48 PM IST

    Early gains for generics in Cymbalta patent expiry: Sources

    Cymbalta, which is used to treat depression and anxiety disorders, lost patent protection on December 12.

  • Buy BOI, YES Bank, Alembic Pharma, Arvind : Dharmesh Kant Dec 23, 2013 11:54 AM IST

    Buy BOI, YES Bank, Alembic Pharma, Arvind : Dharmesh Kant

    Dharmesh Kant of Indianivesh Securities recommends buying Alembic Pharmaceuticals with a target of Rs 220 and Arvind with a target of Rs 136.

  • Bull's Eye: Buy IOC, Nakoda, BOI, YES Bank, Arvind Dec 23, 2013 08:57 AM IST

    Bull's Eye: Buy IOC, Nakoda, BOI, YES Bank, Arvind

    Pankaj Jain of Sunteck Wealthmax recommends buying GMR Infrastructure with a target of Rs 24.95 and Peninsula Land with a target of Rs 43.45.

  • Bull's Eye: Buy MRPL, KPIT Tech; sell PTC India, Voltas Nov 08, 2013 08:59 AM IST

    Bull's Eye: Buy MRPL, KPIT Tech; sell PTC India, Voltas

    Krish Subramanium of Asit C Mehta advises buying Mangalore Refinery and Petrochemicals for a target price of Rs 45.75 and Torrent Pharma for a target price of Rs 512.

  • Bull's Eye: Buy Titan, Bajaj Finance; short LIC Housing Oct 29, 2013 09:04 AM IST

    Bull's Eye: Buy Titan, Bajaj Finance; short LIC Housing

    Dharmesh Kant of India Nivesh Securities advises buying Bajaj Finance with a target price of Rs 1,320 and JB Chemicals with a target price of Rs 99.

  • Bull's Eye: Buy Canara Bank, Jubilant Foodworks, Sesa Goa Sep 24, 2013 08:56 AM IST

    Bull's Eye: Buy Canara Bank, Jubilant Foodworks, Sesa Goa

    Saurabh Mittal of Swadeshi Credits recommends buying Motherson Sumi with a target price of Rs 237 and Canara Bank with a target price of Rs 232.

  • Bull's Eye: Buy Sintex, Voltas, Eros International, PFC Sep 16, 2013 09:01 AM IST

    Bull's Eye: Buy Sintex, Voltas, Eros International, PFC

    Prakash Diwan of Altamount Capital Management recommended buying Hindustan Zinc with a target price of Rs 129.90 and Alembic Pharma with a target price of Rs 145.50.

  • See 20% EBITDA growth in FY14: Alembic Pharma Aug 07, 2013 03:50 PM IST

    See 20% EBITDA growth in FY14: Alembic Pharma

    In an interview to CNBC-TV18, Amin adds that the company, despite the drug pricing policy, will grow at 15 percent.

  • Buy Chambal Fert, Alembic Pharma; sell HPCL: Mukadam Jul 09, 2013 02:30 PM IST

    Buy Chambal Fert, Alembic Pharma; sell HPCL: Mukadam

    Shahina Mukadam of Varun Capital recommends buying Chambal Fertilisers and Chemicals with a target of Rs 40 and advises to sell Hindustan Petroleum Corporation with a target of Rs 227.

  • Bull's Eye: Buy Alembic Pharma, Reliance Power, PTC India Jul 09, 2013 08:52 AM IST

    Bull's Eye: Buy Alembic Pharma, Reliance Power, PTC India

    Sharmila Joshi of Peerless Securities advised buying Alembic Pharma with a target price of Rs 168 and Escorts with a target price of Rs 80.

  • Bull's Eye: Buy IVRCL, GSFC, Tech Mahindra; short Petronet Jun 20, 2013 08:54 AM IST

    Bull's Eye: Buy IVRCL, GSFC, Tech Mahindra; short Petronet

    Rajesh Agarwal of Eastern Financiers advised buying Mahindra Ugine for a target price of Rs 93 and IVRCL for a price target of Rs 17.50.

  • Not impacted by Ranbaxy's negative news: Alembic Pharma May 29, 2013 04:38 PM IST

    Not impacted by Ranbaxy's negative news: Alembic Pharma

    Ranbaxy shares declined a further 2 percent on Wednesday morning after a media report said a prominent hospital in Mumbai had advised doctors to stop using the pharma company's drugs.

  • See 100-120 bps margin improvement in FY14: Alembic Pharma May 06, 2013 01:33 PM IST

    See 100-120 bps margin improvement in FY14: Alembic Pharma

    Alembic Pharma is hopeful to increase operating margin by 100-120 basis points in current financial year on the back of strong growth in international and domestic generic business.

  • Avoid Alembic Pharma, says SP Tulsian Mar 11, 2013 07:57 PM IST

    Avoid Alembic Pharma, says SP Tulsian

    SP Tulsian, sptulsian.com advises traders to avoid Alembic Pharma at current levels.

  • Alembic sees 1% rise in EBITDA on antidepressant drug nod Mar 06, 2013 01:25 PM IST

    Alembic sees 1% rise in EBITDA on antidepressant drug nod

    Alembic Pharmaceuticals expects 100 basis points improvement in its EBITDA as it has earned exclusive rights to sell Pristiq generic tablets for 24 Months.

  • Alembic Pharma likely to touch Rs 82-84, says Tulsian Mar 06, 2013 12:48 PM IST

    Alembic Pharma likely to touch Rs 82-84, says Tulsian

    SP Tulsian of sptulsian.com advised buying Alembic Pharma at around Rs 82-84. He expects the stock to hit these levels in a week.

  • Bull's eye: Buy IndusInd Bank, NHPC, SKS Micro, PFC Mar 06, 2013 08:27 AM IST

    Bull's eye: Buy IndusInd Bank, NHPC, SKS Micro, PFC

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Alembic Pharma has target of Rs 100: SP Tulsian Mar 05, 2013 07:38 PM IST

    Alembic Pharma has target of Rs 100: SP Tulsian

    Alembic Pharma has target of Rs 100, says SP Tulsian, sptulsian.com

Sections